Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)
0.3341 x 5 0.3850 x 22
Post-market by (Cboe BZX)
0.3365 -0.0427 (-11.26%) 04/04/25 [NASDAQ]
0.3341 x 5 0.3850 x 22
Post-market 0.3570 +0.0205 (+6.09%) 19:59 ET
Profile for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Vaxart Inc 170 Harbor Way Suite 300 South San Francisco CA 94080 USA

www.vaxart.com Employees: 105 P: 650-550-3500 F: 650-871-8580

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 76,792
Enterprise Value, $K 51,562
Shares Outstanding, K 228,208
Annual Sales, $ 28,700 K
Annual Net Income, $ -66,950 K
Last Quarter Sales, $ 15,190 K
Last Quarter Net Income, $ -11,990 K
EBIT, $ -66,300 K
EBITDA, $ -58,210 K
60-Month Beta 1.57
% of Insider Shareholders 2.60%
% of Institutional Shareholders 18.05%
Float, K 222,275
% Float 97.40%
Short Volume Ratio 0.56

Growth:

1-Year Return -70.22%
3-Year Return -92.86%
5-Year Return -80.44%
5-Year Revenue Growth 191.08%
5-Year Earnings Growth 61.63%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 03/20/25
Next Earnings Date 05/12/25
Earnings Per Share ttm -0.34
EPS Growth vs. Prev Qtr 16.67%
EPS Growth vs. Prev Year 58.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-11 on 02/14/18

VXRT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -101.79%
Return-on-Assets % -50.01%
Profit Margin % -233.28%
Debt/Equity 0.00
Price/Sales 3.02
Price/Cash Flow N/A
Price/Book 1.46
Book Value/Share 0.26
Interest Coverage -21.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades